ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic

Accelerating COVID-19 Treatment Interventions and Vaccines (ACTIV) was initiated by the US government to rapidly develop and test vaccines and therapeutics against COVID-19 in 2020. The ACTIV Therapeutics-Clinical Working Group selected ACTIV trial teams and clinical networks to expeditiously develo...

Full description

Bibliographic Details
Published in:Journal of Clinical and Translational Science
Main Authors: Maryam Keshtkar-Jahromi, Kevin J. Anstrom, Christina Barkauskas, Samuel M. Brown, Eric S. Daar, William Fischer, Kevin W. Gibbs, Elizabeth S. Higgs, Michael D. Hughes, Prasanna Jagannathan, Lisa LaVange, Christopher J. Lindsell, Seema U. Nayak, Roger Paredes, Mahesh Parmar, Ithan D. Peltan, Michael Proschan, Matthew S. Shotwell, David M. Vock, Tammy Yokum, Stacey J. Adam
Format: Article
Language:English
Published: Cambridge University Press 2024-01-01
Subjects:
ACTIV
COVID-19
clinical trial
design
lessons
Online Access:https://www.cambridge.org/core/product/identifier/S2059866124000013/type/journal_article

Internet

https://www.cambridge.org/core/product/identifier/S2059866124000013/type/journal_article

Similar Items